TechCrunch

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with ...
New York Post

Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business

Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday. Thrive Capital, a venture capital firm, led the ...
Benzinga.com

Alphabet Q2 Earnings: Revenue, EPS Beat Estimates, Google Parent Raises CapEx Outlook Due To 'Strong And Growing' Cloud Demand

Alphabet Inc GOOG GOOGL reported financial results for the second quarter after the market close on Wednesday. Here’s a look at the key details from the period. Q2 Earnings: Google parent Alphabet ...
Investopedia

Alphabet Tops Expectations on Cloud, Search Growth, Boosts Capital Spending Plan

Google parent Alphabet (GOOGL) reported second-quarter revenue and profit that beat analysts' expectations, driven by rising cloud and search sales, and lifted its outlook for capital spending this ...